Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of acetylsalicylic acid on immunoparalysis following human endotoxemia
2016-001971-61Phase 4Completed
- Sponsor
- Radboudumc
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in immunologic paralysis (2 arms), sponsored by Radboudumc. Primary endpoint: Endotoxin tolerance measured by TNFα. Started Jul 2016; status: completed.
02
Drugs
aspirin
03
Conditions
immunologic paralysis
Beyond the preview
Go deeper on 2016-001971-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001971-61.